Takeda Pharmaceutical Co. Ltd. - Operating Expenses

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Operating-Expenses" stands at 2.02 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 0.6637 Trillion JPY for the item "Operating Expenses" represents an increase of 66.03 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 0.6637 Trillion JPY for the item "Operating Expenses" represents an increase of 49.54 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 2.02 Trillion JPY for the item "Operating Expenses" represents an increase of 12.24 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.81 percent compared to the value the year prior.
The 1 year change in percent is 10.81.
The 3 year change in percent is 34.01.
The 5 year change in percent is 43.29.
The 10 year change in percent is 40.54.

The Serie's long term average value is 1.29 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 56.30 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +174.51%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.